Louache F, Debili N, Cramer E, Breton-Gorius J, Vainchenker W
INSERM U91, Hôpital Henri Mondor, Créteil, France.
Blood. 1991 Jan 15;77(2):311-6.
The origin of platelet fibrinogen is controversial. It may arise from two sources: (a) exogenously by endocytosis of plasma fibrinogen, or (b) endogenously by synthesis. We explored the second possibility because we previously demonstrated that the first mechanism does occur. Fibrinogen synthesis by human megakaryocytes (MK) was investigated by in situ hybridization and the polymerase chain reaction (PCR) applied to mRNA. MK differentiating from marrow CFU-MK were cultured in suspension. In situ hybridization using the 35S alpha and beta fibrinogen chain anti-sense riboprobes was totally negative in MK in comparison with negative controls (lambda phage and alpha and beta fibrinogen chain sense riboprobes). In contrast, synthesis of fibrinogen was detected by this technique in a hepatoma cell line (HepG 2). Furthermore, mRNA for alpha and beta chains of fibrinogen was not detected by the PCR performed on mRNA from cultured MK enriched to 90% purity, by the immunomagnetic bead technique, even after Southern blotting of the amplified products. In addition, fibrinogen mRNA was undetected in marrow MK and in platelets by the same technique, whereas a specific megakaryocyte gene transcript (GPIb alpha) was easily detected. These observations demonstrate that the only mechanism responsible for the presence of fibrinogen in platelets is endocytosis of fibrinogen from plasma.
血小板纤维蛋白原的来源存在争议。它可能有两个来源:(a)通过血浆纤维蛋白原的内吞作用从外源性获得,或(b)通过合成从内源性获得。我们探讨了第二种可能性,因为我们之前证明第一种机制确实存在。通过原位杂交和应用于mRNA的聚合酶链反应(PCR)研究了人巨核细胞(MK)的纤维蛋白原合成。从骨髓CFU-MK分化而来的MK在悬浮液中培养。与阴性对照(λ噬菌体以及α和β纤维蛋白原链正义核糖探针)相比,使用35Sα和β纤维蛋白原链反义核糖探针的原位杂交在MK中完全呈阴性。相比之下,通过该技术在肝癌细胞系(HepG 2)中检测到了纤维蛋白原的合成。此外,即使对扩增产物进行Southern印迹分析,通过免疫磁珠技术对纯度达到90%的培养MK的mRNA进行PCR,也未检测到纤维蛋白原α和β链的mRNA。此外,通过相同技术在骨髓MK和血小板中未检测到纤维蛋白原mRNA,而一种特定的巨核细胞基因转录本(GPIbα)却很容易被检测到。这些观察结果表明,血小板中纤维蛋白原存在的唯一机制是从血浆中内吞纤维蛋白原。